Wound Management Proves Strong Potential With Distribution Agreements In Place
OneMedRadio interviewed President and Director Deborah Jenkins Hutchinson and got a glimpse into this emerging growth company.
News
Verisante Technologies Detects Skin Cancer in Less Than A Second
OneMedRadio interviewed Thomas Braun, CEO of Verisante Technologies [CVE:VRS], a medical device company committed to commercializing innovative systems for the early detection of cancer.
Protected: VIDEO: Talking JOBS Act with Christine Jacobs, SEC Advisory Committee Chair
There is no excerpt because this is a protected post.
Editors Note August 30, 2011
Summer is winding down, but activity is heating up in the world of healthcare and emerging life sciences. OneMedSentinel continues coverage of some of the […]
Financings and business developments in the global diagnostics business
Biocept, Inc., a privately-held CLIA-certified laboratory testing company, and Clarient, Inc. (a GE Healthcare Company) say that they will be collaborating on the commercialization of a proprietary blood test for circulating tumor cells…
Rodman and Renshaw presenting Companies
SpectraScience 4:55 Tuesday – North Foyer. NanoViricides 3:15 Tuesday – Starlight South ThermoGenesis 10:00 Tuesday – Metropolitan West EpiCept Corporation 11:15 Monday – Metropolitan West […]
Sept 11-13, 2011 Rodman & Renshaw Global Healthcare Conference
Rodman & Renshaw holds its 13th annual Global Investment Health care Conference this September at the Waldorf=Astoria in New York.
Wound Management Technologies Inks Distribution Deal Worth Initial $2M
Wound Management Technologies, Inc., (OTCQB: WNDM | WNDM.PK) a leader in advanced wound care solutions, recently announced a major distribution deal with Marketing Media Enterprises.
Editor’s Note August 23, 2011
OneMedRadio continues to bring you candid interviews with CEOs of some of the most interesting and innovative micro-cap healthcare and life science companies from around […]
ThermoGenesis Sees Explosive Growth Opportunities in Stem Cells
Mel Engle, CEO of ThermoGenesis [NASDAQ: KOOL] recently discussed with OneMedRadio, the company’s stem cell products and FDA approval that may have groundbreaking implications for the stem cell market.